Navigation Links
Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
Date:10/30/2007

is in 19 multidisciplinary groups. http://www.eortc.be

About Schering-Plough

Schering-Plough Corporation is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 33,500 people around the world. The company's Web site is http://www.scheringplough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to potential market for TEMODAR. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward- looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A, "Risk Factors" in Schering-Plough's third quarter 2007 10-Q.

Reference:

(1)National Brain Tumor Foundation Fact Sheet, "Who Gets Brain Tumors and Why"; 2004


'/>"/>
SOURCE Schering-Plough Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
3. 8-Year Long-term Data Demonstrate Prolonged Overall Survival and Length of Disease Remission with Bexxar
4. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
5. Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates
6. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
7. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
8. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
9. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
10. UCB Presents Long-Term CImzia Data in Crohns Disease
11. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Virginia , 11. Juli 2014 ... von Kameras für die molekulare Bildgebung, ... hat heute die CE-Zulassung für sein ... CE-Zeichen kann Dilon das Produkt jetzt ... auf den Großteil der europäischen Länder ...
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
(Date:7/10/2014)... 10, 2014   Ventana Medical Systems, Inc.  (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... Fenwick & West, a leading technology and life sciences ... joined the firm as a partner in its Life Sciences ... clients as a strategic counselor on a broad range of ... and secretary at AVI BioPharma, Ms. Toshav is based in ...
... 14, 2012 Medical device recalls increased more than ... more than five times as many units than the ... released today. Products impacted by the increase ... Consumer product recalls also increased in the first quarter ...
Cached Medicine Technology:Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 3
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) investigation, Bernstein Liebhard LLP has been ... Food & Drug Administration’s (FDA) Obstetrics and ... explore ways to mitigate the cancer risks associated ... invasive gynecological surgeries. According to a report published ...
(Date:7/11/2014)... Datalogic brings a new and innovative ... wide. With their new Gryphon GD4400 and ... the devastating MRSA, which claimed 5,500 lives, becomes more ... 2D and the Gryphon GM4400-HC 2D readers can scan ... read barcodes off of troublesome LCD monitors, smartphones, and ...
(Date:7/11/2014)... people with sex addiction, pornography affects the brain in ... addicts as they consume drugs, a new study finds. ... patients who have compulsive sexual behavior and healthy volunteers. ... Dr. Valerie Voon, of the University of Cambridge in ... research involved 19 men with sex addiction and a ...
(Date:7/11/2014)... Ticket Down is a reliable source for ... When it comes to the summer concert schedule, it just isn’t ... is one of the biggest names in country music and one ... out on his “That’s My Kind of Night” tour featuring Lee ... be making through the rest of the summer and into the ...
(Date:7/11/2014)... According to a new market research ... Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application ... Transportation, Agriculture) & Geography - Global Trends & Forecasts ... Things market was worth $1029.5 Billion in 2013, and ... an estimated CAGR of 4.08% from 2014 to 2020. ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4
... 50% of fertility clinics in the US are allowing parents ... It also found that in 9 percent of the cases ... ,Dr. William Gibbons, president of the Society for Assisted ... most cases the gender selection tests were being performed for ...
... Refugees residing on temporary protection visas (TPVs) are ... mental health problems than those with permanent protection ... psychiatrists have revealed. ,Anxiety, post-traumatic stress ... for TPV holders than for PPV holders, mental ...
... steady partners, according to a new study. One in 10 men ... admitted that it was a regular habit. // ,"Approximately ... relationship," said Dr Tamsin Groom, of the Sandyford Initiative in Glasgow. ... used condoms in most cases except when they were out of ...
... vaccines to prevent severe gastroenteritis should now be made ... the latest issue of the Medical Journal of Australia. ... having such an effective tool to prevent a common, ... and Ruth Bishop say in an editorial. ...
... kills hundreds of thousands worldwide, infect by stealth. ... the very immune system// cells the body relies ... ,Just how Salmonella escapes detection by macrophages, ... infection, has seemed impossibly complicated, a needle-in-a-haystack proposition ...
... The U.S. physician workforce has released a study saying ... aging US population. Researchers from the University// of Utah ... said that the health needs of the population were ... report, titled "Family Physician Workforce Reform: Recommendations of the ...
Cached Medicine News:Health News:Detention, Uncertainty take their Toll on the Mental Health of Refugees 2Health News:Experts Call for Rotavirus Vaccine for All 2Health News:An Infectious Agent of Deception, Exposed Through Proteomics 2Health News:Call To Increase Family Physicians 2Health News:Call To Increase Family Physicians 3
... Flash Cards is designed ... heart, veins, and arteries ... It uses the time ... from BryanEdwards.com and displays ...
... Consult is the perfect quick consult ... diagnosis and management of both common ... of chest pain to the management ... quick reference makes the most of ...
... Unbound Surgery, published by ... innovative digital resource that ... and leading edge technology. ... that is specifically engineered ...
... guide to the management of ... offers a response from leading ... the more common, and often ... cardiology. It is a "how-to" ...
Medicine Products: